Exposure and/or sensitivity to stress have been implicated as conferring risk for development of Alzheimer's disease (AD). Although the basis for such a link remains unclear, we previously reported differential involvement of corticotropin-releasing factor receptor (CRFR) 1 and 2 in acute stress-induced tau phosphorylation (tau-P) and solubility in the hippocampus. Here we examined the role of CRFRs in tau-P induced by repeated stress and the structural manifestations of altered tau solubility. Robust tau-P responses were seen in WT and CRFR2 null mice exposed to repeated stress, which were sustained at even 24 h after the final stress exposure. A portion of phosphorylated tau in these mice was sequestered in detergent-soluble cellular fractions. In contrast, CRFR1 and CRFR double-KO mice did not exhibit repeated stress-induced alterations in tau-P or solubility. Similarly, treatment with CRFR1 antagonist attenuated repeated stress-induced tau-P. Using histochemical approaches in a transgenic CRFR1 reporter mouse line, we found substantial overlap between hippocampal CRFR1 expression and cells positive for phosphorylated tau after exposure to repeated stress. Ultrastructural analysis of negatively stained extracts from WT and CRFR2 null mice identified globular aggregates that displayed positive immunogold labeling for tau-P, as well as conformational changes in tau (MC1) seen in early AD. Given that repeated stress exposure results in chronic increases in hippocampal tau-P and its sequestration in an insoluble (and potentially prepathogenic) form, our data may define a link between stress and an AD-related pathogenic mechanism.
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neurofibrillary tangles | western blot | pathology | electron microscopy A lzheimer's disease (AD) is definitively characterized by the presence of β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs). NFTs are insoluble intracellular inclusions composed of aggregated hyperphosphorylated forms of the cytoskeletal protein tau that accumulate initially within the hippocampal formation (1) . A critical step in NFT formation is thought to be the transition of these phosphorylated tau species into aggregated insoluble fibrils. Hyperphosphorylated tau has a reduced ability to bind microtubules and has been reported to self-aggregate into paired helical filaments (PHFs), which compose NFTs (2, 3) . The development of NFTs is positively correlated with cognitive decline and neuronal loss in AD (4, 5) .
The majority of AD cases are of sporadic origin, with age the primary risk factor. In addition, recent work has implicated environmental influences, such as stress, as also conferring risk for the development of AD (6, 7) . In line with this, stress exposure can increase Aβ production and induce deficits in hippocampal cell proliferation and contextual memory in AD transgenic mice (8, 9) . Moreover, exposure to a variety of physiological stressors can activate tau kinases and induce tau phosphorylation (tau-P) in rodents (reviewed in refs. 10-16). We previously reported that acute exposure to an emotional stressor, physical restraint, which models everyday life stresses in humans, dramatically increases tau-P and kinase activity in the hippocampus (17), a key structure in learning and memory and the initial site of tau pathology in AD (1) . These effects occurred independent of stress-induced alterations in glucocorticoid secretion, but were blocked by genetic or pharmacologic disruption of signaling through corticotropin-releasing factor receptor (CRFR) type 1 (CRFR1) and exaggerated in CRFR2-deficient mice. Although the transience of acute stress-induced tau-P raises important questions as to the pathological relevance of the phenomenon, repeated restraint exposures (14 consecutive d) resulted in cumulative increases in phosphorylated tau species, a portion of which were sequestered in an insoluble, potentially prepathogenic form (17) . Here we extend that analysis to examine the possible role of CRFRs in the altered phosphorylation, solubility, and conformation of tau seen after exposure to repeated stress.
Results

CRFR Involvement in Repeated
Stress-Induced Tau-P. Our previous findings indicated differential regulation by CRFRs of acute stress-induced tau-P in the hippocampus (17) . To determine whether this effect generalizes to chronic/repeated stress conditions, we examined levels of tau-P at the AD-relevant PHF-1 (serine 396/404 ) and AT8 (serine 202 /threonine 205 ) sites in mice lacking CRFR1, CRFR2, or both receptors and in both soluble and detergent-soluble hippocampal fractions, after a single exposure (acute stress) or 14 consecutive daily exposures (repeated stress) to a 30-min restraint (Fig. 1) . Separate cohorts of each stressed group were killed at 20 min or 24 h after their final (or only) restraint session to allow assessment of acute vs. persistent/ cumulative effects of stress experience on tau-P.
Results in WT mice support our previous findings (17) in indicating a cumulative effect of repeated stress on tau-P at both sites examined [ Fig. 1A ; compare acute (A) and repeated (R) 24-h lanes]. With respect to CRFR status, these results extend previous findings regarding CRFR dependence to the repeated stress condition. Specifically, we found no responses in CRFR1-deficient mice that significantly exceeded those in unstressed WT or CRFR1 −/− controls (all P > 0.10). Responses of CRFR2 mutants were either similar to or, in some conditions (R-20 for AT8; A-24 for both epitopes), greater than those of genetically intact animals. In addition, mice deficient in both CRFRs demonstrated no response to acute or repeated stress, similar to CRFR1 mutants.
To test whether effects seen in the hippocampus extend to other brain areas enriched in CRFR expression, we examined isocortical and cerebellar extracts from the same cohort of animals. We found no significant change in tau-P at the PHF-1 or AT8 sites as a function of genotype or stress in either region (P > 0.05, ANOVA) (Fig. S1) .
With respect to the solubility of PHF-1-and AT8-phosphorylated tau in hippocampal extracts, we previously documented persistent effects of stress (i.e., at 24 h after the final exposure) in both the soluble and detergent-soluble fractions of WT mice after repeated restraint, but not after acute restraint (17) . Examining the involvement of CRFR in this effect revealed the absence of stress-induced tau-P responses in CRFR1 and double-KO mice in both cellular fractions and at both phosphorylation sites, except for a small increment in soluble PHF-1 tau in extracts from CRFR1 mutants at 20 min. Repeatedly stressed CRFR2 null mice had significantly increased levels of AT8 and PHF-1 detergent-soluble tau species at 24 h after final exposure compared with their WT counterparts (P < 0.001, WT R-24-DS vs. R2 mutant R-24-DS) (Fig.  1B) . Levels of detergent-soluble tau also were significantly greater in R2 mutants at the 24-h time point relative to the 20-min time point (P < 0.001), suggesting continued sequestration of phosphorylated tau after cessation of stress. Collectively, these findings indicate that the CRFR genotype dependence seen in acutely restrained mice extends to the effects of repeated stress on tau-P and solubility. Data from double-KO mice suggest that CRFR2 involvement is dependent on CRFR1 and apt to lie upstream of the underlying central circuitry.
Effects of CRFR1 Antagonists. Because data from germ line KO animals might be confounded by developmental or indirect effects, we examined whether pharmacologic blockade of CRFR1 signaling could mitigate repeated stress-induced tau-P. Again using PHF-1 and AT8 antibodies, we confirmed that pretreatment with the small-molecule CRFR1 antagonist antalarmin (18) at 20 mg/kg/d i.p. blocked acute stress-induced tau-P, but had no effect on tau-P at either 20 min or 24 h after the last of 14 daily repeated restraint sessions. Given the side effects associated with longerterm use of antalarmin (Fig. S2) , we repeated the experiment using a second-generation CRFR1 antagonist, R121919 (19) , with more favorable toxicity and solubility profiles (ClogP = 4.52; ChemAxon freeware).
When given by injection or osmotic minipump at 20 mg/kg/d, R121919 displayed efficacy in disrupting repeated stress-induced tau-P, with no apparent negative side effects. Minipump delivery was the most effective technique, completely blocking the effects of both acute and repeated stress at the 20-min time point (Fig. 2 , lanes A-D-20 and R-D-20). Drug treatment via this route also disrupted the cumulative effects of repeated stress, assayed at 24 h after the final restraint session, by >50% relative to repeatedly stressed, vehicle-treated mice (all P < 0.001), although these values remained significantly elevated compared with those of unstressed controls (all P < 0.05). These findings support at least a partial specific dependence of repeated stress-induced tau-P on CRFR1 signaling.
Cellular Localization of Stress-Induced Tau-P. Immunohistochemical preparations were used to compare (semiquantitatively; see Methods) the distribution and relative strength of stress-induced tau-P (PHF-1 antibody) in the hippocampi of mice (n = 4 or 5 In WT mice, both acute and repeated stress provoked marked and comparable short-term (20 min) increases in tau-P at both the AT8 and PHF-1 phosphorylation sites, but only the repeated stress effects were sustained at 24 h. In contrast, CRFR1 and double-KO mice (DBL) were unresponsive under all stress conditions tested. CRFR2
−/− mice also showed robust stress-induced tau-P; persistent elevations seen at 24 h after acute stress in this genotype are consistent with previous evidence of inhibitory effects of CRFR2 signaling on this parameter (17) . (B) Solubility of phosphorylated tau after repeated stress exposure. As seen in WT animals exposed to repeated stress, portions of phosphorylated tau in CRFR2 mutant mice were found in detergent-soluble fractions. Statistical analysis indicated that CRFR2 animals accumulated less insoluble tau compared with WT counterparts at 20 min after stress, but significantly more at the 24 h time point (P < 0.001). Phosphorylated tau was virtually undetectable in this fraction of extracts from CRFR1-deficient and double-KO mice. *P < 0.05 compared with NS of the same genotype; † P < 0.05 compared with WT of the same stress condition.
per group) subjected to acute vs. repeated restraint ( Fig. 3 and Fig. S3 ). Consistent with previous findings (17), mice killed at 30 min after a single restraint episode displayed prominent increases in PHF-1 labeling of perikarya in the hilar region of the dentate gyrus and in the deepest aspects of the granule cell layer and adjoining subgranular zone compared with unstressed controls (Fig. 3 , Top). In Ammon's horn (Fig. 3 , Middle), labeled neurons were scattered throughout the pyramidal cell layer of fields CA1-3; small, multipolar cells in the dendritic zones, presumably interneurons, also displayed enhanced PHF-1 immunolabeling (Fig. 3, CA1 , Acute 20-min). Acute stress-induced up-regulation of PHF-1 labeling was transient; the labeling intensity in mice killed at 24 h after restraint did not differ discernibly from that seen in controls. PHF-1 labeling in repeatedly stressed mice displayed a similar distribution as acute stress-induced tau-P, although the density and intensity of cellular labeling was consistently reduced in mice killed at either 20 min or 24 h after their final restraint episode (Fig. 3 , Top, Acute 20-min vs. Repeated 20-min and Repeated 24-hr). No consistent differences were seen between the two repeatedly stressed groups, whose labeling appeared consistently, albeit only moderately, stronger than that of unstressed controls.
To identify potential substrates underlying CRFR1-dependent stress effects, we sought to determine whether stressinduced tau-P localized to CRFR1-expressing hippocampal neurons. Because of issues with the specificity and/or sensitivity of available CRFR antisera, we used a transgenic mouse line that expresses EGFP under control of CRFR1 promoter/enhancer sequences (20) . Reporter expression in this line marks CRFR1 expression with high sensitivity, resolution, and accuracy, as demonstrated by direct comparisons with CRFR1 mRNA expression (20) . Tissue from reporter mice subjected to acute or repeated restraint, as above, was prepared for dual fluorescence localization of EGFP and PHF-1 immunoreactivity (Fig. 3, Bottom) . Confocal microscopic analysis of doubly stained sections identified hilar neurons of the dentate gyrus as the dominant cellular site of PHF-1-positive tau colocalization with CRFR1-driven EGFP, approaching complete overlap in acutely stressed preparations (Fig. 3, Bottom) . More sporadic stress-induced perikaryal tau-P signals were observed in Ammon's horn and also localized to EGFP-positive neurons, as were occasional granule cells of the dentate gyrus. In keeping with the decrement in PHF-1 immunolabeling seen in repeatedly stressed animals, dual labeling was most prominent in acutely stressed mice. Dentate hilar neurons were the dominant seat of residual PHF-1 localization to CRFR1-positive cells under repeated stress conditions.
Structural Phenotype of Detergent-Soluble Phosphorylated Tau After
Stress. NFTs consisting of PHFs are a diagnostic feature of AD. PHFs can be imaged by transmission electron microscopy of ultrathin sections or extracts of the AD brain, where they comprise ∼10-to 20-nm-diameter cylindrical filaments with a helical period of ∼80 nm (21) . These filaments can be decorated by immunogold labeling to affirm the presence of phosphorylated tau or conformationally modified tau species in radioimmunoprecipitation assay (RIPA) extracts of AD brains, which contain the bulk of dispersed PHFs (22, 23) (Fig. 4 A and F) . We used similar methods to image hippocampal RIPA extracts from WT 3 . Cellular localization of stress-induced tau-P. Immunoperoxidase staining for PHF-1 of the dentate gyrus (Top) and CA1 field (Middle) in hippocampal sections from unstressed control mice and mice killed at 20 min after acute restraint or at 20 min and 24 h after the last of 14 repeated daily stress sessions. Labeling for tau-P is most prominent in neurons in the hilus of the dentate gyrus, with secondary cellular accumulations in dentate granule cells (gr), pyramidal cells (pyr), and presumed interneurons in the basal (so) and apical (sr, slm) dendritic zones of field CA1. Cellular staining for PHF-1 tau is more robust after acute stress than after repeated stress. (Bottom) Dual-immunofluorescence labeling for PHF-1 tau (red) and CRFR1-driven eGFP (green) in sections from CRFR1 reporter mice killed at 20 min after their sole restraint session (acute) or the last of 14 daily restraint sessions (repeated). Separate and merged channels are shown from the acutely stressed mouse, and only the merged channel is shown for the repeated stress situation (separate channels for all conditions are shown in Fig. S3 ). Nearly complete overlap between PHF-1 and eGFP labeling is seen in hilar neurons of the dentate gyrus (arrows denote examples). PHF-1 labeling of cells is less robust in the repeated stress example. (Scale bars: 100 μm.) mice subjected to acute or repeated restraint stress, as described above. In this material, we observed widely scattered negatively stained structures of consistent form (rounded globular aggregates 40-100 nm in diameter) that labeled consistently for phosphorylated and conformationally modified tau (4-10 gold particles/aggregate using either MC1 or PHF-1 antibody; Fig. 4 D and E). Background immunogold labeling was very low (11.9 particles/μm 2 ; Fig. 4B ). Purifying the extracts using a pan-tau antibody (tau-5) markedly increased the density of rounded aggregates (average diameter, 69 nm) to as high as 7.2/μm 2 .
Aggregates labeled for either marker were seen only in extracts from repeatedly stressed mice; unstressed controls and animals subjected to acute stress did not display either consistent negative staining of any structural elements or above-background immunogold labeling (e.g., Fig. 4B ).
Discussion
A potential link between stress and tau pathology was first indicated by studies reporting that exposure to any of a variety of potent homeostatic insults resulted in marked increases in tau-P in brain regions affected in AD (reviewed in ref. 10). Our finding of comparably robust hippocampal tau-P responses to restraint (17), a mild-moderate stressor of the so-called "emotional" category that shares key similarities in how it affects the brain with paradigms that model fear, anxiety, and social stress (24) , raised the prospect that the tau-P response might be relevant to everyday life stresses experienced by humans. This resonated with, and suggested possible underpinnings of, findings in a longitudinal clinical pathological study of aging and AD that implicated stress experience and/or sensitivity as risk factors for developing AD (6, 7). The transience of acute stress-induced tau-P raised questions about the pathological relevance of this phenomenon, however. Insight into this issue was provided by the finding, replicated here, that repeated, but not acute, restraint exposure gives rise to persistent and cumulative increases in hippocampal tau-P, a portion of which exhibits reduced solubility characteristics associated with prepathological tau aggregates.
Acute restraint-induced tau-P responses in hippocampus abate by 90 min after stress (17) . Here we used a 24-h poststress time point to probe for lasting and/or cumulative alterations in tau-P/solubility. Whether effects observed at this time represent permanent changes is unclear. In general, detergent-soluble aggregated tau species from the AD brain are characterized as a separate pool distinct from heat-stable, soluble, and functional tau that can interact with tubulin and stabilize microtubules (22, 25, 26) . Data from AD mouse models suggest that although the early-stage tau pathology burden is reversible, aggregated forms of hyperphosphorylated tau species might be permanent (27) . In light of our findings in repeated stress suggestive of nonfilamentous early pathogenesis, some degree of reversibility seems possible and even likely. Less clear is whether any reversal might occur spontaneously or would require intervention.
Our results in null mice indicate a strict dependence on CRFR1 of the repeated stress effects on tau-P and solubility. Although whether the incomplete blockade of tau-P response by treatment with the small-molecule CRFR1 antagonist R121919 may be related to technical limitations (e.g., dose, stability, delivery) or involvement of additional mediators remains to be determined, the pharmacologic and genetic data collectively support a specific and central role for CRFR1 signaling in the phenomenon. CRFR2 null mice showed indications of exaggerated tau-P responses to repeated stress, but not to the degree seen in our previous study involving acute restraint (17) . The fact that mice deficient in both receptors showed no effect of stress on tau-P or solubility supports a mediating role for CRFR1 and a dependence of CRFR2 effects on CRFR1 integrity.
In the present study, stress effects on tau-P exhibited specificity to the hippocampus. Extracts of other prominent sites of CRFR1 expresson (isocortex and cerebellum; ref. 28 ) from the same mice used in the genotype/solubility analyses (Fig. 1 ) demonstrated no reliable variations in tau-P as a function of treatment. These brain regions are capable of displaying increments in tau-P in response to ostensibly more potent stressors (29, 30) . Whether their capacity to do so depends on the nature and/or intensity of stress, and whether CRFR signaling may be involved, remain to be determined.
Corticotropin-releasing factor (CRF) is best known as the principal hypothalamic peptide governing pituitary-adrenal responses to diverse insults. CRF is widely distributed in the brain and has been implicated in complementary autonomic and behavioral adjustments to stress as well. Its effects, along with those of related peptides (urocortin 1-3), are mediated via two G protein-coupled receptors, CRFR1 and CRFR2, which are differentially distributed in the brain (28) . CRFR1 is more expansively expressed, including in regions (isocortex and hippocampus) vulnerable to AD pathology. Our findings with tau-P add to a growing list of contexts in which the two CRFRs are both involved in sculpting CNS reactions to stressful situations (31) .
Our histochemical analyses provide insight into the cellular localization of stress-induced tau-P localization in hippocampus. Dentate hilar neurons were identified as the dominant seat, with secondary accumulations in scattered granule cells of the dentate gyrus and pyramidal cells and presumed interneurons of Ammon's horn. In contrast to results obtained by Western blot analysis, immunohistochemical labeling for tau-P showed a clear tendency to habituate with repeated stress exposure, possibly reflecting diminished in situ accessibility of antibodies to tau species or aggregates exhibiting reduced solubility characteristics. All localizations, except ostensibly interneuronal ones, occurred predominantly in CRFR1-expressing neurons. Hilar neurons, the principal focus of phosphorylated tau accumulation, give rise to Fig. 4 . Immunoelectron microscopy of tau filaments and aggregates. (A and F) Paired helical filaments from an AD brain, negatively stained and immunogold-labeled using antibodies PHF-1 (A) or MC1 (F), the latter recognizing a conformational change in tau seen in early AD. (B and C) Nonimmunolabeled, negatively stained RIPA extracts from unstressed control (B) and repeatedly stressed (C) mice. Mice subjected to 14 d of repeated restraint stress show negatively stained round/globular aggregates (40-100 nm diameter) that were not seen in unstressed or acutely stressed mice, or in soluble extracts of repeatedly stressed mice. (D and E) These aggregates could be decorated by immunogold labeling for both PHF-1 (D) and MC1 (E). (Scale bars: 100 nm; bars in A, B, and D also apply to F, C, and E, respectively.) commissural and associational projections to dentate granule cells, and thus are in position to broadly influence information flow throughout the intrinsic circuitry of the hippocampus. If the hippocampus proper is to be considered as a site of action of CRFR1 ligands in driving tau-P, a key question to be addressed is the source of such ligands. We are unaware of any reports of CRF or urocortin-1 expression in extrinsic projections to hippocampus.
The fact that repeated stress results in sequestration of phosphorylated tau to insoluble fractions is potentially indicative of a contribution to pathogenesis. An unexpected and potentially significant finding of the present study is that a portion of phosphorylated tau induced by repeated stress assumes a definite macromolecular structure that can be decorated with the MC1 antibody, which binds a conformationally altered form of tau, recognized as among the earliest pathological changes in this protein in AD (32, 33) . The size and shape of these structures are reminiscent of those of aggregates assembled from N-terminally truncated human tau under cell-free conditions (34) . This suggests that tau species accumulating in our preparations might be truncated as a result of stress, although our Western blot analyses have not provided definitive results on this issue. When truncated at the N terminus, tau cannot form filaments in cellfree systems, but may do so in vivo, and has been implicated in NFT formation and neurodegeneration (35, 36) . Given the granular appearance of the aggregates, another potential structural candidate for these aggregates are tau oligomers, which are monomeric or dimeric accumulations of highly phosphorylated or truncated tau (37, 38) . Tau oligomers have been detected in tau transgenic mice and in presymptomatic AD (1, (39) (40) (41) . They are composed of ∼40 tau molecules and can form fibrils once the oligomers reach a diameter of ∼20 nm (39, 40) . Whether the aggregates that we observed truly represent oligomers is open to question, given that the majority were >40 nm in diameter and exhibited no filamentous structures. Apart from a study involving conditional neuronal expression of a tumor antigen (42), we are unaware of any previous reports of aggregate or fibrillar structures derived purely from WT murine tau, complicating comparisons with human tau-based structures. The finding that potentially prepathological tau aggregates can occur after a limited duration of intermittent exposure to a moderate stressor is striking, and may indicate that stress alone is capable of promoting pathogenic changes in tau.
In summary, our findings are consistent with the possibility that chronic stress exposure may contribute to the development and progression of tau pathology in AD in a CRFR-dependent manner. Stress is recognized as a precipitating or exacerbating factor in an extraordinary range of systemic and CNS (including neurodegenerative) disorders. Beyond the proposed relationship between chronically elevated glucocorticoid levels and neuronal vulnerability in AD (43, 44) , relatively little is known about how other stress mediators might contribute to pathogenesis. The central CRF-signaling system has been broadly implicated in multiple modes of stress adaptation. Convergent interactions of CRFR1-and CRFR2-dependent mechanisms have been described in sculpting responses to a range of diverse stressors. Here we provide evidence that CRFR signaling mechanisms also can influence mechanisms of AD pathogenesis by affecting tau-P and solubility in the hippocampus. This identifies CRFR1 as a potential target for intervention in AD, as well as in the gamut of additional neurodegenerative disorders in which tau pathology figures prominently, including forms of frontotemporal dementia, amyotrophic lateral sclerosis, Down syndrome, and Creutzfeldt-Jacob, Pick's, and Prion diseases (45) . Small-molecule CRFR1 antagonists are currently being evaluated for the treatment of major depression, other anxiety-related disorders (46) , and at least one systemic condition [irritable bowel syndrome (47) ]. The present findings may encourage consideration of additional applications in the realm of age-related neurodegenerative disease.
Methods CRFR KO Mice. Mutant mice and littermate WT controls were bred from heterozygote breeder pairs of established lines (48, 49) derived from backcrosses of founder mice to achieve a pure C57BL/6 background. Genotyping was performed by PCR analysis of tail DNA, and appropriate males were used for experimentation at 15-22 wk of age. Pregnant females bearing fetuses carrying a mutant CRFR1 allele received drinking water with 10 mg/L of corticosterone on days E12-P14 to prevent early mortality due to pulmonary dysplasia (48) . Because CRFR1 −/− mice exhibit adrenal cortical agenesis, experimental animals were reinstated on corticosterone supplementation for 21 d before testing, to allow the nocturnal bias in appetitive behavior to approximate the circadian fluctuation in circulating hormone levels. Blood samples were collected at the time of sacrifice, and plasma corticosterone levels were measured by RIA to assess the effectiveness of the replacement regimen. The University of California at San Diego's Institutional Animal Care and Use Committee approved all experimental protocols.
CRFR1 Reporter Mice. CRFR reporter mice (CRFR1-EGFP) were generated using a construct in which the first exon of CRFR1 was replaced with DNA encoding EGFP within a 225-kb bacterial artificial chromosome (20) . As with other transgenic lines generated using this approach, normal function of the receptor is not affected (50) . Males were used for experimentation at 15-22 wk of age.
Restraint Stress. Acute restraint stress involved placing mice in ventilated 50-mL conical tubes for 30 min. Repeated stress involved 14 consecutive daily exposures of this nature. Animals were killed at either 20 min or 24 h after stress. Control mice were handled comparably, but were not otherwise manipulated.
Pharmacologic Manipulations. A small-molecule CRFR1-selective antagonist, either antalarmin (a gift from Dr. G. Chrousos, University of Athens Medical School, Athens, Greece) (18) or R121919 (19) , was administered at 20 mg/kg/d by i.p. injection or by a 14-d ALZET osmotic minipump. Animals receiving i.p. injections were given the drug 20 min before stress exposure. All animals were handled twice daily for 28 d before experimentation, and received daily mock i.p. injections to minimize the stress of injection at testing. Antalarmin and R121919 were solubilized in equal volumes of absolute ethanol and Cremaphor EL (Sigma-Aldrich) as described previously (18, 19, 51) .
Western Blot Analysis. To avoid potentially confounding effects of anesthetics on tau-P (52), all mice were killed by cervical dislocation. Each animal was decapitated, and the hippocampus, cortex, and cerebellum were rapidly dissected and frozen on dry ice. Tissues were homogenized in RIPA buffer [50 mM Tris-HCl (pH 7.4), 0.1% SDS, 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 nM NaCl, 1 mM EDTA, 1 mM EGTA] containing protease and phosphatase inhibitors. RIPA fractions were obtained by centrifuging twice at 40,000 × g for 20 min, after which the supernatant was collected. For analysis of tau solubility, sequential fractionation of RAB and RIPA extracts was performed as described previously (17) using established protocols (53, 54) . Tissues were first homogenized in high-salt RAB and then centrifuged at 40,000 × g for 40 min. The resultant supernatant was collected (soluble RAB fraction). Pellets were resuspended in RIPA buffer and processed to obtain detergent-soluble fractions. For quantitative Western blot analysis, background subtraction was performed, and band intensity readings were obtained using ImageJ software as described previously (17) .
Immunohistochemistry. Mice were perfused with 4% paraformaldehyde and processed for immunohistochemistry, as described previously (17) . Frozen sections were cut at 30 μm on a sliding microtome and stored at −20°C in cryoprotectant solution until use. Sections were then prepared for localization of tau-P using PHF-1 (1:500 dilution) as described previously (17) .
Comparisons of the strength of immunolabeling as a function of stress experience were based on semiquantitative (rating scale) assessments of cell number and staining intensity by observers blind to subjects' treatment status. Material to be compared was processed in tandem using common batches of diluted antisera.
Immunoelectron Microscopy. Hippocampal RIPA fractions were examined by immunogold EM to probe for structural changes as a result of stress exposure. To increase the density of tau structures for EM analysis, RIPA extracts were immunoprecipitated overnight using a pan-tau antibody (Tau-5; Millipore) covalently linked to protein G beads (Pierce Crosslink Immunoprecipitation Kit). Proteins were eluted with 50 mM glycine (pH 2.8) and brought to pH 7.0 with 1 N NaOH for EM analysis. Extracts were applied to 200-mesh carbon coated copper grids previously exposed to plasma glow discharge for 90 s. Grids were exposed for 10 min to blocking buffer (PBS containing 2% BSA and 0.1% fish gelatin) and then incubated in primary antibody overnight. Immunogold-labeled secondary antibody (10 nm gold; British Biocell International) was applied, after which the grids were washed and negatively stained with uranyl acetate (4% in dH20) and then examined using a JEOL 100CXII transmission electron microscope. Images were collected with a MegaView III digital camera.
Antibodies. Well-characterized AD tau antibodies AT8 (1:1,000; Pierce Endogen), Tau-5 (1:1,000; Millipore), MC1 and PHF-1 (1:500; gifts from Dr. P. Davies, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY) were used for detection of conformational change or phosphorylated residues on mouse tau, as described previously (17) . β-actin (1:2,000; Sigma-Aldrich) was used as a control for protein loading.
Statistical Analyses. Optical density readings from Western blots were analyzed by two-way ANOVA using Prism4 software (GraphPad Software). Individual group means were compared using the Bonferroni multiplecomparison test. Data are presented as mean ± SEM.
